- Home
- SELF vs CGTX Comparison
SELF vs CGTX Comparison
Compare SELF & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | CGTX |
|---|---|---|
| Founded | 1983 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 94.5M |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SELF | CGTX |
|---|---|---|
| Price | $5.10 | $1.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 27.7K | ★ 624.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $12,530,280.00 | N/A |
| Revenue This Year | $1.59 | N/A |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $34.57 | ★ N/A |
| Revenue Growth | ★ 2.79 | N/A |
| 52 Week Low | $4.73 | $0.22 |
| 52 Week High | $5.83 | $3.83 |
Technical Indicators
Market Signals| Indicator | SELF | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.55 | 52.08 |
| Support Level | $5.02 | $1.00 |
| Resistance Level | $5.09 | $1.19 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 36.67 | 80.56 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.